JP2024523422A5 - - Google Patents
Info
- Publication number
- JP2024523422A5 JP2024523422A5 JP2023578035A JP2023578035A JP2024523422A5 JP 2024523422 A5 JP2024523422 A5 JP 2024523422A5 JP 2023578035 A JP2023578035 A JP 2023578035A JP 2023578035 A JP2023578035 A JP 2023578035A JP 2024523422 A5 JP2024523422 A5 JP 2024523422A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- replaced
- groups
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110673571 | 2021-06-17 | ||
| CN202110673571.1 | 2021-06-17 | ||
| PCT/CN2022/099053 WO2022262789A1 (zh) | 2021-06-17 | 2022-06-16 | 一种抗肿瘤化合物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523422A JP2024523422A (ja) | 2024-06-28 |
| JP2024523422A5 true JP2024523422A5 (https=) | 2025-02-19 |
Family
ID=84526879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578035A Pending JP2024523422A (ja) | 2021-06-17 | 2022-06-16 | 抗腫瘍化合物およびその応用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240358848A1 (https=) |
| EP (1) | EP4357348A4 (https=) |
| JP (1) | JP2024523422A (https=) |
| KR (1) | KR20240022626A (https=) |
| CN (1) | CN119604509A (https=) |
| AU (1) | AU2022294861B2 (https=) |
| CA (1) | CA3223304A1 (https=) |
| IL (1) | IL309457A (https=) |
| MX (1) | MX2023015462A (https=) |
| TW (1) | TW202313125A (https=) |
| WO (1) | WO2022262789A1 (https=) |
| ZA (1) | ZA202400544B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114805377A (zh) * | 2021-01-29 | 2022-07-29 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
| JP2025524970A (ja) * | 2022-07-27 | 2025-08-01 | 明慧医藥（杭州）有限公司 | 抗体－薬物コンジュゲートおよびその使用 |
| KR20250111373A (ko) | 2022-11-25 | 2025-07-22 | 밍훼이 파마슈티컬 (항저우) 리미티드 | 항종양 화합물 및 이의 응용 |
| WO2025241867A1 (zh) * | 2024-05-24 | 2025-11-27 | 明慧医药（杭州）有限公司 | 抗b7-h4抗体药物偶联物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| JP2006316040A (ja) | 2005-05-13 | 2006-11-24 | Genentech Inc | Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法 |
| ITMI20061473A1 (it) * | 2006-07-26 | 2008-01-27 | Indena Spa | Derivati della camptotecina ad attivita antitumorale |
| ES2773710T3 (es) * | 2012-10-11 | 2020-07-14 | Daiichi Sankyo Co Ltd | Enlazadores para conjugados de anticuerpo - fármaco |
| EP3368092B9 (en) * | 2015-10-29 | 2020-07-29 | Novartis AG | Antibody conjugates comprising toll-like receptor agonist |
| JP6679762B2 (ja) * | 2017-01-17 | 2020-04-15 | 第一三共株式会社 | 抗ｇｐｒ２０抗体及び抗ｇｐｒ２０抗体−薬物コンジュゲート |
| WO2019034176A1 (zh) * | 2017-08-18 | 2019-02-21 | 四川百利药业有限责任公司 | 一种喜树碱-抗体偶联物 |
| CN113766933B (zh) * | 2019-06-28 | 2024-09-06 | 上海复旦张江生物医药股份有限公司 | 一种抗体偶联药物、其中间体、制备方法及应用 |
| CN112125915A (zh) * | 2019-09-18 | 2020-12-25 | 四川百利药业有限责任公司 | 一种喜树碱衍生物及其偶联物 |
| CN114805377A (zh) * | 2021-01-29 | 2022-07-29 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
-
2022
- 2022-06-16 IL IL309457A patent/IL309457A/en unknown
- 2022-06-16 TW TW111122382A patent/TW202313125A/zh unknown
- 2022-06-16 AU AU2022294861A patent/AU2022294861B2/en active Active
- 2022-06-16 EP EP22824264.0A patent/EP4357348A4/en active Pending
- 2022-06-16 CN CN202280083620.9A patent/CN119604509A/zh active Pending
- 2022-06-16 CA CA3223304A patent/CA3223304A1/en active Pending
- 2022-06-16 KR KR1020247001831A patent/KR20240022626A/ko active Pending
- 2022-06-16 JP JP2023578035A patent/JP2024523422A/ja active Pending
- 2022-06-16 WO PCT/CN2022/099053 patent/WO2022262789A1/zh not_active Ceased
- 2022-06-16 MX MX2023015462A patent/MX2023015462A/es unknown
- 2022-06-16 US US18/570,784 patent/US20240358848A1/en active Pending
-
2024
- 2024-01-16 ZA ZA2024/00544A patent/ZA202400544B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024523422A5 (https=) | ||
| TWI871998B (zh) | 抗her3抗體-藥物結合物 | |
| JP2022511351A5 (https=) | ||
| JP2012516896A5 (https=) | ||
| KR20230162159A (ko) | 항-her2 항체-약물 접합체 | |
| JP2023519261A5 (https=) | ||
| US20250320310A1 (en) | A method for programmatically managing antibody disulfide bonds site-specific modification | |
| JP2025508779A5 (https=) | ||
| JP2024536798A5 (https=) | ||
| WO2024041543A1 (en) | A method of preparing an antibody with thiol group site-specific modifications and use of tcep | |
| WO2025261478A1 (en) | Antibody drug conjugates and applications thereof | |
| WO2024041541A1 (en) | A novel thiol reductant, method and use thereof | |
| TH2101001650A (th) | ลิแกนด์-ดรักคอนจูเกตของสารแอนะล็อกของเอกซาทีแคน, วิธีการเตรียมสำหรับคอนจูเกตนั้น และการประยุกต์ใช้คอนจูเกตดังกล่าว | |
| RU2021110631A (ru) | Конъюгат лиганд-лекарственное средство аналога экзатекана, способ его получения и его применение | |
| RU2021110824A (ru) | Конъюгат антитело к b7h3-аналог экзатекана и его применение в медицине | |
| EA051826B1 (ru) | Пептидные конъюгаты цитотоксинов в качестве терапевтических средств | |
| NZ787254B2 (en) | Novel B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof |